Error: Could not add to watchlist. X
+ Watchlist

BB Adamant Global Generika

ADGLGRN:SW
95.44
CHF
0.99
1.03%
As of 10/19/2017
Fund Type
Open-End Fund
52Wk Range
78.98 - 96.54
1 Yr Return
9.33%
YTD Return
18.57%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
96.43
52Wk Range
78.98 - 96.54
1 Yr Return
9.50%
YTD Return
18.57%
Fund Type
Open-End Fund
Objective
Foreign Blend
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 10/19/2017)
95.44
Total Assets (m CHF) (on 10/19/2017)
75.402
Inception Date
03/02/2015
Last Dividend (on 01/18/2017)
0.692
Dividend Indicated Gross Yield
0.73%
Fund Managers
OLIVER KUBLI / JOHN MANIERI
Front Load Fee
-
Back Load Fee
-
Redemption Fee
-
12b-1 Fee
-
Current Mgmt Fee
-
Expense Ratio
0.02%

Top Fund Holdings

Name Position Value % of Fund
6.00 m 7.35 m 5.53
25.00 k 6.13 m 4.61
45.00 k 5.98 m 4.50
30.00 k 5.55 m 4.18
200.00 k 5.36 m 4.03
6.00 m 5.19 m 3.90
1.50 m 5.17 m 3.89
35.00 k 5.10 m 3.84
80.00 k 4.84 m 3.64
52.22 k 4.69 m 3.53
Profile
BB Adamant Global Generika Fund is an open-ended investment company incorporated in Switzerland. The Fund's aim is to generate long-term capital growth through active management by investing in companies within the generic sector. The Fund's portfolio will be concentarted to around 30 to 50 stocks which fully meet Adamant's strict selection criteria.
Address
Swisscanto Fondsleitung AG
Bahnhofstrasse 9
8001 Zuerich
Switzerland
Phone
Tel: +41 58 344 49 00